Doctor profile · Federal record
Dr. Melinda Dunlap, MD
Hematology & Oncology Physician (CMS: Medical Oncology) · Internal Medicine Physician · Internal Medicine Physician · Tulsa, OK
- NPI 1609096668
- Accepts Medicare
- MIPS 82.5 / 100 · 2023
- 22 yrs in practice
- Licensed in 3 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
12697 E 51St St
Tulsa, OK 741466236
(918) 505-3200
fax (918) 505-3253
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- May 8, 2014
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (3)
- Oklahoma #28469 · Texas #M6116 · Pennsylvania #MD431408
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1609096668. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
142,157
Distinct HCPCS
10
Medicare allowed
$2,657,866
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 18,750 | 19 | $1 | |
J9299 |
Injection, nivolumab, 1 mg | 13,380 | 24 | $30 | |
J9271 |
Injection, pembrolizumab, 1 mg | 12,500 | 33 | $54 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11,035 | 127 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 9,623 | 42 | $0 | |
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 7,920 | 11 | $0 | |
J1627 |
Injection, granisetron, extended-release, 0.1 mg | 7,500 | 58 | $6 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 7,400 | 18 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 6,120 | 21 | $48 | |
J0185 |
Injection, aprepitant, 1 mg | 5,460 | 36 | $2 |
In context: peer comparison
Among 18 peers in this city , average services per provider: 1,283. This provider delivers 111× the peer median.Open Payments
Industry payments received
All-time total
$538
Transactions
22
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $215.57 | |
| Novartis Pharmaceuticals Corporation | 3 | $65.86 | |
| BeiGene USA, Inc. | 1 | $34.10 | |
| Janssen Biotech, Inc. | 1 | $31.34 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $28.96 | |
| Alexion Pharmaceuticals, Inc. | 1 | $21.23 | |
| Agios Pharmaceuticals, Inc. | 1 | $19.38 | |
| Merck Sharp & Dohme LLC | 1 | $16.64 | |
| ABBVIE INC. | 1 | $16.42 | |
| Ipsen Biopharmaceuticals, Inc | 1 | $16.23 | |
| GlaxoSmithKline, LLC. | 1 | $15.62 | |
| Stemline Therapeutics Inc. | 1 | $15.21 | |
| Geron Corporation | 1 | $14.96 | |
| GENZYME CORPORATION | 1 | $13.45 | |
| Eisai Inc. | 1 | $13.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,511
Patients
422
Total drug cost
$969,783
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 321 | 68 | $8,322 |
| Tamoxifen Citrate | Generic | 161 | 39 | $4,920 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 106 | 42 | $2,678 |
| Omeprazole | Generic | 106 | 28 | $2,016 |
| Prochlorperazine Maleate | Generic | 101 | 58 | $1,214 |
| Ondansetron Hcl | Generic | 93 | 57 | $972 |
| Hydroxyurea | Generic | 87 | 15 | $2,333 |
| Letrozole | Generic | 81 | 22 | $2,831 |
| Levothyroxine Sodium | Generic | 75 | 12 | $766 |
| Dexamethasone | Generic | 69 | 33 | $1,402 |
Hospital affiliations
Frequently asked questions
What is Dr. Melinda Dunlap's medical specialty?
Dr. Melinda Dunlap practices Hematology & Oncology Physician in Tulsa, OK.
Where does Dr. Melinda Dunlap practice?
Dr. Melinda Dunlap practices at 12697 E 51St St, Tulsa, OK 741466236. Office phone: 9185053200.
What is Dr. Melinda Dunlap's NPI?
Dr. Melinda Dunlap's National Provider Identifier (NPI) is 1609096668, issued by NPPES.
Does Dr. Melinda Dunlap accept Medicare assignment?
Yes. Dr. Melinda Dunlap accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Melinda Dunlap commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, nivolumab, 1 mg (HCPCS J9299); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.